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Background
Chronic spontaneous urticaria (CSU) patients demonstrate
functional autoantibodies against high affinity receptors of
IgE (FcerI). Autologous serum skin test(ASST)is mostly
used in chronic spontaneous urticaria to show its auto-
reactivity. ASST positive patients represent a severe group
which can be benefited from autoserum therapy (AST).
So, aim of our study is to evaluate the efficacy of auto-
serum therapy in ASST positive patients.
Methods
AST was performed on 20 ASST positive patients (M:F =
12:8 ; age range = 19 - 45 years ; duration of the disease=
6months to 5 years). ASST was done by injecting patients
own serum and normal saline as control in a dose of
0.05ml and readings were taken after 30 minutes. A
wheal and flare response of more than 1.5mm diameter
was considered as positive. ASST positive patients were
given autoserum therapy in a dose of 0.05ml /kg intra-
muscularly once a week for 9 weeks. To evaluate the
response we studied urticaria activity score (UAS), der-
matology life quality index (DLQI) and disease severity
by the no. of antihistamines used.
Results
We found that out of 20 ASST positive patients 9 patients
had significant response in terms of decrease UAS and
antihistamines used with improvement in DLQI, 6 patients
had moderate response and 5 patients had poor response.
Conclusions
Autoserum therapy is effective in significant no. of ASST
positive patients.
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